FI954218A0 - Bentsopyraaneja kaliumkanavan avaajina - Google Patents

Bentsopyraaneja kaliumkanavan avaajina

Info

Publication number
FI954218A0
FI954218A0 FI954218A FI954218A FI954218A0 FI 954218 A0 FI954218 A0 FI 954218A0 FI 954218 A FI954218 A FI 954218A FI 954218 A FI954218 A FI 954218A FI 954218 A0 FI954218 A0 FI 954218A0
Authority
FI
Finland
Prior art keywords
pct
formula
image
dashed line
covalent bond
Prior art date
Application number
FI954218A
Other languages
English (en)
Swedish (sv)
Other versions
FI954218A (fi
FI115055B (fi
Inventor
Alexander Roderick Mackenzie
Sandra Marina Monaghan
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939304917A external-priority patent/GB9304917D0/en
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of FI954218A publication Critical patent/FI954218A/fi
Publication of FI954218A0 publication Critical patent/FI954218A0/fi
Application granted granted Critical
Publication of FI115055B publication Critical patent/FI115055B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
FI954218A 1993-03-10 1995-09-08 Menetelmä uusien kaliumkanavan avaajina käyttökelpoisten 6-(tetratsol-5-yyli)bentso[b]pyraanijohdannaisten valmistamiseksi FI115055B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB939304917A GB9304917D0 (en) 1993-03-10 1993-03-10 Benzopyrans
GB9304917 1993-03-10
GB939308368A GB9308368D0 (en) 1993-03-10 1993-04-22 Benzopyrans
GB9308368 1993-04-22
EP9400637 1994-03-04
PCT/EP1994/000637 WO1994020491A1 (en) 1993-03-10 1994-03-04 Benzopyranes as potassium channel openers

Publications (3)

Publication Number Publication Date
FI954218A FI954218A (fi) 1995-09-08
FI954218A0 true FI954218A0 (fi) 1995-09-08
FI115055B FI115055B (fi) 2005-02-28

Family

ID=26302564

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954218A FI115055B (fi) 1993-03-10 1995-09-08 Menetelmä uusien kaliumkanavan avaajina käyttökelpoisten 6-(tetratsol-5-yyli)bentso[b]pyraanijohdannaisten valmistamiseksi

Country Status (23)

Country Link
US (1) US5677324A (fi)
EP (1) EP0690855B1 (fi)
JP (1) JP3137649B2 (fi)
CN (1) CN1119014A (fi)
AT (1) ATE146468T1 (fi)
AU (1) AU674940B2 (fi)
BR (1) BR9406818A (fi)
CA (1) CA2155837C (fi)
CZ (1) CZ230895A3 (fi)
DE (1) DE69401201T2 (fi)
DK (1) DK0690855T3 (fi)
EG (1) EG20542A (fi)
ES (1) ES2097041T3 (fi)
FI (1) FI115055B (fi)
GR (1) GR3022517T3 (fi)
HU (1) HUT73784A (fi)
IL (1) IL108841A0 (fi)
MY (1) MY110494A (fi)
NO (1) NO953573L (fi)
NZ (1) NZ262897A (fi)
PL (1) PL310553A1 (fi)
SG (1) SG42910A1 (fi)
WO (1) WO1994020491A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
WO2002015902A1 (en) * 2000-08-23 2002-02-28 Merck & Co., Inc. Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists
EP1715869A1 (en) * 2004-02-12 2006-11-02 Warner-Lambert Company LLC Method of stimulating hair growth
WO2014001363A1 (en) * 2012-06-25 2014-01-03 Clevexel Pharma Novel tetrazole derivatives and their use as potassium channel modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1479518A (en) * 1973-12-27 1977-07-13 Erba Carlo Spa 5,6-benzo-ypsilon-pyrone derivatives
DE3811017A1 (de) * 1988-03-31 1989-10-19 Hoechst Ag Ungesaettigte n-benzopyranyllactame
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate

Also Published As

Publication number Publication date
BR9406818A (pt) 1996-09-10
ATE146468T1 (de) 1997-01-15
EP0690855A1 (en) 1996-01-10
NZ262897A (en) 1997-06-24
NO953573D0 (no) 1995-09-11
CZ230895A3 (en) 1995-12-13
MY110494A (en) 1998-06-30
AU6282694A (en) 1994-09-26
FI954218A (fi) 1995-09-08
DK0690855T3 (da) 1997-06-02
EP0690855B1 (en) 1996-12-18
US5677324A (en) 1997-10-14
WO1994020491A1 (en) 1994-09-15
SG42910A1 (en) 1997-10-17
ES2097041T3 (es) 1997-03-16
IL108841A0 (en) 1994-06-24
FI115055B (fi) 2005-02-28
JPH08503225A (ja) 1996-04-09
CA2155837A1 (en) 1994-09-15
JP3137649B2 (ja) 2001-02-26
HU9501918D0 (en) 1995-09-28
DE69401201T2 (de) 1997-04-17
CA2155837C (en) 1999-07-27
HUT73784A (en) 1996-09-30
PL310553A1 (en) 1995-12-27
NO953573L (no) 1995-09-11
CN1119014A (zh) 1996-03-20
GR3022517T3 (en) 1997-05-31
DE69401201D1 (de) 1997-01-30
AU674940B2 (en) 1997-01-16
EG20542A (en) 1999-07-31

Similar Documents

Publication Publication Date Title
DE69327541D1 (en) 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
ES2185054T3 (es) Derivados de benzopirano.
PT638075E (pt) Inibidor da reaccao de maillard
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
FI954218A0 (fi) Bentsopyraaneja kaliumkanavan avaajina
ES2128572T3 (es) Utilizacion de los derivados de cefem como agentes antimetastaticos.
SE8501988D0 (sv) Iminothiazolidine derivatives
DE69430074T2 (de) Analgetische 4-arylisoindolen
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
ATE181327T1 (de) Indolderivate

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115055

Country of ref document: FI

MA Patent expired